Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in Early-Stage Cervical Cancer
NCT04723875Phase 3Active, not recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jan 2021
- Primary completion
- Jan 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, docetaxel, cisplatin, carboplatin in Cervical Cancer (CC), sponsored by Huazhong University of Science and Technology. Started Jan 2021; status: active, not recruiting.
02
Drugs
paclitaxeldocetaxelcisplatincarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04723875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04723875.